IOL Chemicals and Pharmaceuticals Ltd

Ticker: IOLCP
Decent 68/100

☆ Add to Watchlist

Investing Reference

Price
97.61
Market Cap
2865.12
Debt/Equity
0.0694
ROE %
6.127
PB
1.6977
Promoter %
52.623
Pledge %
0.000
1Y Rev Growth %
-2.831
5Y Rev Growth %
NP Margin %
4.809
NP Margin 5Y Avg %

Trading Reference

1M Return %
-17.714
6M Return %
53.741
1Y Return %
12.610
% Away 52W High
29.761
% Away 52W Low
69.757
Daily Volume
1515760
Investment Verdict
Buy
Score 78/100 · Position size: 40%
Long-term fundamentals are strong. Suitable for investors with a 1–3+ year horizon.
Trading Verdict
Avoid
Score 36/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

IOL Chemicals and Pharmaceuticals Ltd is currently trading near a key support level, with recent price action showing increased volume on upward movements. If the stock can maintain above this support, there is a potential upside towards the next resistance level. However, if it breaks below the support, a downside risk is present.
Upside Probability: 15%   |   Downside Probability: 10%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

IOL Chemicals and Pharmaceuticals Ltd is a leading manufacturer of specialty chemicals and pharmaceuticals in India. Catering to diverse industries, including healthcare and agriculture, the company is recognized for its commitment to quality and innovation. With a strong focus on sustainability, IOL is positioned to meet the growing demand for high-quality chemical products in both domestic and international markets. Its robust R&D capabilities and strategic partnerships enhance its competitive edge, making it a trusted choice for customers and investors alike.

  • Established leader in specialty chemicals and pharmaceuticals
  • Serves diverse sectors like healthcare and agriculture
  • Strong commitment to quality and sustainability
  • Robust R&D capabilities driving innovation
  • Strategic partnerships enhance market position

Investment Thesis

IOL Chemicals and Pharmaceuticals Ltd stands out due to its robust promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. These factors position the company for sustained growth and profitability in the competitive pharmaceutical sector.

  • Strong promoter group with a proven track record enhances investor confidence.
  • Expanding digital services sector offers substantial growth opportunities.
  • Valuation metrics indicate IOL is undervalued compared to industry peers.
  • Diverse product portfolio mitigates risks and supports revenue stability.
  • Commitment to R&D ensures innovation and competitive advantage.

Opportunity vs Risk

Opportunities
  • Growing demand for pharmaceuticals
  • Expansion into international markets
  • Strong product pipeline
  • Government support for healthcare sector
  • Rising healthcare awareness in India
Risks ⚠️
  • Regulatory changes affecting operations
  • Intense competition in the industry
  • Supply chain disruptions
  • Fluctuating raw material costs
  • Dependency on key customers

Peer Perspective

IOL Chemicals trades at a discount to peers like Aarti Industries and Alkyl Amines, primarily due to margin volatility. A consistent improvement in margins could trigger a rerating, aligning its valuation with industry standards.

Future Outlook

IOL Chemicals and Pharmaceuticals Ltd is well-positioned for growth, driven by strong demand in the pharmaceutical sector; however, successful execution of its expansion plans and stringent cost control will be crucial for maximizing shareholder value.

AI FAQs for Retail Users

  • Q: What does IOL Chemicals and Pharmaceuticals Ltd do?
    A: IOL Chemicals and Pharmaceuticals Ltd manufactures bulk drugs and intermediates for the pharmaceutical industry.
  • Q: Is IOL Chemicals listed on the stock exchange?
    A: Yes, IOL Chemicals is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) in India.
  • Q: What are the main products of IOL Chemicals?
    A: The company primarily produces active pharmaceutical ingredients (APIs) and specialty chemicals.
  • Q: How has IOL Chemicals performed recently?
    A: Recent performance can be checked through financial reports and stock market updates.
  • Q: What should I consider before investing in IOL Chemicals?
    A: Consider the company's financial health, market position, and your own investment goals.
📊 Stock Investment Checklist (100 Points)
IOL Chemicals and Pharmaceuticals Ltd • Updated: 2025-09-17 02:47:15
  • 10
    Business
    High
    The sector is growing with increasing demand for specialty chemicals, but competition is high.
  • 10
    Growth
    High
    Consistent revenue growth over the past few years, but profit margins are under pressure.
  • 10
    Profitability
    High
    ROE and ROCE are decent, but OCF has shown volatility.
  • 8
    Valuation
    High
    P/E and P/B ratios are higher than industry averages, indicating potential overvaluation.
  • 7
    Balance
    High
    Moderate debt levels, but liquidity ratios are satisfactory.
  • 6
    Governance
    Good
    Promoter holding is stable, but there are concerns about pledging.
  • 5
    Drivers
    Good
    Growth drivers are present, but execution risks remain significant.
  • 5
    Technicals
    Good
    Market sentiment is mixed with low liquidity.
Final Score & Verdict
Score 68 / 100 • Decent
IOL Chemicals and Pharmaceuticals Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 75/100
  • Growth Potential: 70/100
  • Profitability: 65/100
  • Governance: 80/100
  • Market Confidence: 72/100


More Like This

Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.